Author

D. Shang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:Arabidopsis· 1 Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1

Frequent Co-Authors

C. Gao· 1 shared C. Wang· 1 shared F. Li· 1 shared L. Huang· 1 shared L. Liu· 1 shared L.-Z. Tao· 1 shared N. Luo· 1 shared Q. Xie· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCell Biology

C. Gao

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Engineered AIM-based Selective Autophagy to Degrade Proteins and Organelles

N. Luo, D. Shang, Z. Tang, X. Huang, L.-Z. Tao, L. Liu, C. Gao, Y. Qian, Q. Xie, F. Li

The paper introduces a method to degrade specific proteins and organelles using engineered autophagy receptors, demonstrating its effectiveness in plant and transient expression systems.

bioRxiv · Jun 11, 2021 · PreprintCell Biology

Synergistic Therapy of Doxorubicin with Cationic Anticancer Peptide L-K6 Reverses Multidrug Resistance in Cancer Cells in vitro via P-glycoprotein Inhibition

C. Wang, L. Huang, R. Li, Y. Wang, X. Wu, D. Shang

This study shows that the cationic peptide L-K6 enhances doxorubicin's effectiveness in drug-resistant cancer cells by inhibiting P-glycoprotein function and expression.

bioRxiv · Feb 2, 2021Pharmacology & Toxicology